Evolent Health Valuation
| 9EH Stock | EUR 10.70 0.60 5.31% |
At this time, the firm appears to be overvalued. Evolent Health shows a prevailing Real Value of €10.27 per share. The current price of the firm is €10.7. Our model computes the value of Evolent Health from reviewing the firm fundamentals such as Shares Outstanding of 111.05 M, profit margin of (0.01) %, and Current Valuation of 3.01 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Evolent Health's price fluctuation is slightly risky at this time. Calculation of the real value of Evolent Health is based on 3 months time horizon. Increasing Evolent Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evolent stock is determined by what a typical buyer is willing to pay for full or partial control of Evolent Health. Since Evolent Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolent Stock. However, Evolent Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.7 | Real 10.27 | Hype 10.7 | Naive 8.56 |
The real value of Evolent Stock, also known as its intrinsic value, is the underlying worth of Evolent Health Company, which is reflected in its stock price. It is based on Evolent Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Evolent Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Evolent Health helps investors to forecast how Evolent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolent Health more accurately as focusing exclusively on Evolent Health's fundamentals will not take into account other important factors: Evolent Health Total Value Analysis
Evolent Health is presently estimated to have takeover price of 3.01 B with market capitalization of 3.69 B, debt of 215.68 M, and cash on hands of 172.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Evolent Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.01 B | 3.69 B | 215.68 M | 172.86 M |
Evolent Health Investor Information
About 15.0% of the company shares are owned by insiders or employees . The book value of Evolent Health was presently reported as 8.6. The company recorded a loss per share of 0.19. Evolent Health had not issued any dividends in recent years. Based on the key indicators obtained from Evolent Health's historical financial statements, Evolent Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Evolent Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Evolent implies not a very effective usage of assets in November.Evolent Health Ownership Allocation
Evolent Health holds a total of 111.05 Million outstanding shares. The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Also note that almost eight million one hundred twenty-nine thousand six invesors are currently shorting Evolent Health expressing very little confidence in its future performance.Evolent Health Profitability Analysis
The company reported the revenue of 1.35 B. Net Loss for the year was (19.16 M) with profit before overhead, payroll, taxes, and interest of 316.58 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Evolent Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Evolent Health and how it compares across the competition.
About Evolent Health Valuation
The stock valuation mechanism determines Evolent Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Evolent Health. We calculate exposure to Evolent Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evolent Health's related companies.Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people.
8 Steps to conduct Evolent Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Evolent Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Evolent Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Evolent Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Evolent Health's revenue streams: Identify Evolent Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Evolent Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Evolent Health's growth potential: Evaluate Evolent Health's management, business model, and growth potential.
- Determine Evolent Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Evolent Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |